| 【Company Research】BeiGene (BGNE US) – Product sales soared in 2Q with improved cost efficiency |
| 【Company Research】Transfer of Coverage |
| 【Company Research】Termination of Coverage |
| 【Company Research】Kweichou Moutai (600519 CH) – 2Q Rev/NP +20.4/21.0% as pre-announced |
| 【Company Research】WuXi AppTec (603259 CH) – Impressive margin improvement in 1H23 |
| 【Company Research】China Auto Sector – Jul NEV: All-time high sales for seven brands |
| 【Company Research】Yum China (9987 HK) – Likely to be resilient and outperform in 2H23E |
| 【Company Research】Yum China (YUMC US) – Likely to be resilient and outperform in 2H23E |
| 【Company Research】Greentown Management (9979 HK) – Earnings in-line; Mgmt. changes imply a new round of expansion |
| 【Company Research】Hutchmed (13 HK) – Eyes on the FDA approval of fruquintinib in Nov |
公司地址：香港中环花园道三号冠君大厦45-46楼
电话：（852）3900-0888 传真：（852）3761-8788
招银国际版权所有 Copyright © 2019-2026 CMB International Capital Corporation Limited. All rights reserved.
